Douglas A. Dachille - Aug 17, 2021 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Barbara Bispham, Attorney-in-Fact
Stock symbol
BBIO
Transactions as of
Aug 17, 2021
Transactions value $
$0
Form type
4
Date filed
8/26/2021, 05:15 PM
Previous filing
Jul 1, 2021
Next filing
Jan 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Stock Option (right to buy) Award $0 +49.9K $0.00 49.9K Aug 17, 2021 Common Stock 49.9K $49.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in three annual installments after August 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.